{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["28(11)"],"submitter":["Lewis JW"],"pubmed_abstract":["A SARS-CoV-2 P.1 (Gamma) variant outbreak occurred at a skilled nursing facility in Washington, USA, in April 2021. Effectiveness of 2 doses of mRNA vaccines against P.1 infection among residents in this outbreak was 75.0% (95% CI 44.5%-88.7%), similar to effectiveness for other pre-Delta variants among long-term care residents."],"journal":["Emerging infectious diseases"],"pagination":["2338-2341"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9622236"],"repository":["biostudies-literature"],"pubmed_title":["Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021."],"pmcid":["PMC9622236"],"pubmed_authors":["Fleming-Dutra KE","Harrison C","Gacetta M","Loughran J","Varghese J","Deng L","Clark S","Lewis JW","Jernigan JA"],"additional_accession":[]},"is_claimable":false,"name":"Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021.","description":"A SARS-CoV-2 P.1 (Gamma) variant outbreak occurred at a skilled nursing facility in Washington, USA, in April 2021. Effectiveness of 2 doses of mRNA vaccines against P.1 infection among residents in this outbreak was 75.0% (95% CI 44.5%-88.7%), similar to effectiveness for other pre-Delta variants among long-term care residents.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-04T07:45:13.53Z","creation":"2025-04-04T07:45:13.53Z"},"accession":"S-EPMC9622236","cross_references":{"pubmed":["36170764"],"doi":["10.3201/eid2811.221043"]}}